Atrial fibrillation - Interventional therapy with respect to age;Vorhofflimmern - Interventionelle differentialtherapie unter besonderer berücksichtigung des lebensalters

Deutsche Medizinische Wochenschrift

Volumn 130, Issue 12, 2005, Pages 721-725

  Lewalter, Thorsten ^a   Luderitz B ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; FLECAINIDE; PROPAFENONE;

AGED; CATHETER ABLATION; CLINICAL FEATURE; ELDERLY CARE; HEART ATRIUM FIBRILLATION; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; PHARMACODYNAMICS; PROPHYLAXIS; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; CARDIOVERSION; DEFIBRILLATOR; FOLLOW UP; HEART ATRIUM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 17144421652     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-865086     Document Type: Review

References (26)

1. Bielik H, Yang A, Schwab JO et al. Klinische Ergebnisse der Katheterablation von Antiarrhythmika-induziertem Vorhofflattern bei Patienten mit rekurrierendem Vorhofflimmern. Herzschr Elektrophys 2003; 14: 8-14
2. Chen SA, Hsieh MH, Tai CT et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins. Electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999; 100: 1879-1886
3. Deisenhofer I, Schneider MA, Bohlen-Knauf M et al. Circumferential mapping and electric isolation of pulmonary veins in patients with atrial fibrillation. Am J Cardiol 2003; 91: 159-163
4. Fang MC, Chang Y, Hylek EM, Rosand J, Greenberg SM, Go AS, Singer DE. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 2004; 141: 745-752
5. Haissaguerre M, Jais P, Shah D et al. Spontaneous Initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666
6. Huang DT, Monahah KM, Zimetbaum P et al. Hybrid pharmacological and ablative therapy: a novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol 1998; 9: 462-469
7. Lewalter Th, Lüderitz B. Arzneimitteltherapie der Herzrhythmusstörungen. Internist 2000; 41: S22-S33
8. Lewalter T, Yang A, Schwab JO et al. Hybridtherapie des Vorhofflimmerns - eine neue therapeutische Alternative. Dtsch Ärztebl 2003; 100/ 36: C1821-1824
9. Lüderitz B. Herzrhythmusstörungen. 5. Aufl (Hrsg). Springer, Berlin Heidelberg New York Tokyo, 1998
10. Moe G, Abildskov JA. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J 1959; 58: 59-70
11. Morady F. Radiofrequency catheter ablation of cardiac arrhythmias. N Engl J Med 1999; 340: 534-544
12. Nabar A, Rodriguez LM, Timmermans C, Smeets JL, Wellens HJ. Radiofrequency ablation of "class IC atrial flutter" in patients with resistant atrial fibrillation. Am J Cardiol 1999; 83: 785-787
13. Nabar A, Rodriguez LM, Timmermans C, Mechelen R, Wellens HJJ. Class 1C antiarrhythmic drug induced atrial flutter: electrocardiographic and electrophysiological findings and their importance for long-term outcome after right atrial isthmus ablation. Heart 2001; 85: 424-429
14. Oral H, Scharf C, Chugh A et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 2003; 108: 2355-2360
15. Pappone C, Oreto G, Lamberti F et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation 1999; 100: 1203-1208
16. Pappone C, Oreto G, Rosanio S et al. Atrial electroanatomical remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 2001; 104: 2539-2544
17. Pappone C, Oral H, Santinelli V et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation 2004; 109: 2724-2726
18. Ouyang F, Bänsen D, Ernst S, Schaumann A, Hachiya H, Chen M, Chun J, Falk O, Antz M, Kuck KH. Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation 2004; 110: 2090-2096
19. Reithmann C, Hoffmann E, Spitzberger G et al. Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation. Eur Heart J 2000; 21: 565-572
20. Scanavacca MI, D'Avila A, Parga J, Sosa E. Left atrial-esophageal fistula following radiofrequency catheter ablation fibrillation. J Cardiovasc Electrophysiol 2004; 15: 960-962
21. Schumacher B, Jung W, Lewalter T, Vahlhaus C, Wolpert C, Lüderitz B. Radiofrequency ablation of atrial flutter due to administration of Class 1C antiarrythmic drugs for atrial fibrillation. Am J Cardiol 1999; 83: 710-713
22. Stabile G, Simone A, Turco P et al. Response to flecainide infusion predictors long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation. J Am Coll Cardiol 2001; 37: 1639-1644
23. Tai CT, Ching CE, Lee SH et al. Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone; electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction. J Cardiovasc Electrophysiol 1999; 10: 1180-1187
24. The Atrial Fibrillation Follow-up Investigation of Rhythm Management New Engl J Med 2002; 347: 1825-1833
25. Yu WC Hsu TL, Cheng HC et al. Focal stenosis of pulmonary vein after application of radiofrequency energy in patients with paroxysmal atrial fibrillation. PACE 1999; 22: 712
26. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation. Executive Summary. Circulation 2001; 104: 2118-2150